PREVENAR13.EU

Prevenar13.eu > Home

Summary of Prevenar 13* product characteristics. Welcome to Prevenar13.eu. The European Commission has granted Pfizer Inc a European marketing authorization for its pneumococcal conjugate vaccine, Prevenar 13* (Pneumococcal Polysaccharide Conjugate Vaccine [13-valent, adsorbed]). Prevenar 13 is indicated for active immunization for the prevention of invasive disease, pneumonia, and acute otitis media caused by 13 Streptococcus pneumoniae serotypes in infants and children from 6 weeks to 5 years of age.

http://www.prevenar13.eu/

OVERVIEW OF prevenar13.eu

TRAFFIC RANK

>1,000,000

REVIEWS

0

PAGES IN THIS WEBSITE

7

LINKS TO THIS WEBSITE

CONTACTS

ADDRESSES

SOCIAL LINKS

ONLINE SINCE

WEBSITE DETAILS

SEO

PAGES

SIMILAR SITES

TRAFFIC RANK FOR PREVENAR13.EU

TODAY'S RATING

>1,000,000

TRAFFIC RANK - AVERAGE PER MONTH

BEST MONTH

February

AVERAGE PER DAY Of THE WEEK

HIGHEST TRAFFIC ON

Monday

TRAFFIC BY CITY

Sign up

CUSTOMER REVIEWS

Average Rating: 4.1 out of 5 with 11 reviews

5 star

8

4 star

0

3 star

1

2 star

0

1 star

2

Hey there! Start your review of prevenar13.eu

AVERAGE USER RATING

Write a Review

WEBSITE PREVIEW

LOAD TIME

CONTACTS AT PREVENAR13.EU

ADD CONTACT

Login

TO VIEW CONTACTS

Remove Contacts

FOR PRIVACY ISSUES

CONTENT

PAGES IN
THIS WEBSITE

7

SSL

EXTERNAL LINKS

0

SITE IP

216.146.46.10

LOAD TIME

0 sec

SCORE

6.2

PAGE TITLE

Prevenar13.eu > Home | prevenar13.eu Reviews

<META> DESCRIPTION

Summary of Prevenar 13* product characteristics. Welcome to Prevenar13.eu. The European Commission has granted Pfizer Inc a European marketing authorization for its pneumococcal conjugate vaccine, Prevenar 13* (Pneumococcal Polysaccharide Conjugate Vaccine [13-valent, adsorbed]). Prevenar 13 is indicated for active immunization for the prevention of invasive disease, pneumonia, and acute otitis media caused by 13 Streptococcus pneumoniae serotypes in infants and children from 6 weeks to 5 years of age.

<META> KEYWORDS

1 print

2 create pdf

3 sitemap

4 worldwide

5 site

6 press release

7 accessibility statement

8 accesskeys

9 coupons

10 reviews

CONTENT

Page content here

KEYWORDS ON PAGE

print,create pdf,sitemap,worldwide,site,press release,accessibility statement,accesskeys

CONTENT-TYPE

utf-8

GOOGLE PREVIEW

Prevenar13.eu > Home | prevenar13.eu Reviews

https://prevenar13.eu

Summary of Prevenar 13* product characteristics. Welcome to Prevenar13.eu. The European Commission has granted Pfizer Inc a European marketing authorization for its pneumococcal conjugate vaccine, Prevenar 13* (Pneumococcal Polysaccharide Conjugate Vaccine [13-valent, adsorbed]). Prevenar 13 is indicated for active immunization for the prevention of invasive disease, pneumonia, and acute otitis media caused by 13 Streptococcus pneumoniae serotypes in infants and children from 6 weeks to 5 years of age.

INTERNAL PAGES

prevenar13.eu

1

Sitemap

http://www.prevenar13.eu/sitemap.aspx

Summary of Prevenar 13* product characteristics. This site is intended for residents of Europe, Middle East and Africa. Some of the documents on this site are PDF (portable document format). PDF files require Adobe Acrobat Reader; click here to download this free program.

2

Prevenar13.eu > Compliance > Access Keys

http://www.prevenar13.eu/accesskeys.aspx

This site uses the access key attribute which provides a set of keyboard shortcuts for common navigational tasks. Internet Explorer (PC) - Hold down the ALT key, press the number of the access key, release both keys then press ENTER:. Alt S enter - Skip navigation. Alt 1 enter - Home page. Alt 2 enter - Accessibility Statement. Alt 3 enter - Sitemap. Alt 7 enter - Privacy Policy. Alt 8 enter - Terms and conditions. Alt 9 enter - Contact Us. Alt 0 enter - Access key details. Shift Alt S - Skip navigation.

3

Wyeth HtmlToPDFConvert

http://www.prevenar13.eu/DesktopModules/WyethHtmlToPdf/HtmlToPdfConvert.aspx

Wyeth HTML to PDF Converter. Html-Code is not available! Please click here to get back to the Wyeth-Page.

4

Press release

http://www.prevenar13.eu/home/press-release-153.aspx

Summary of Prevenar 13* product characteristics. Pfizer Receives European Authorization for Prevenar 13* for the Prevention of Pneumococcal Disease in Infants and Young Children. Prevenar 13 to provide the broadest coverage of any pneumococcal conjugate vaccine for infants and young children -. December 11, 2009. Other pediatric regulatory filings for Prevnar 13 are in advanced stages of review in various countries spanning six continents. Prevenar 13 is also being studied in global Phase III clinica...

5

Prevenar13.eu > Compliance > Country Residence Notice

http://www.prevenar13.eu/countryresidence.aspx

The following information is intended for use only by residents of Europe, the Middle East and Africa. Countries outside of Europe, the Middle East and Africa may have regulatory requirements or medical practices that are different than those in Europe, the Middle East and Africa and may require reference to different or additional information. Therefore, this information may not be appropriate outside of Europe, the Middle East and Africa.

UPGRADE TO PREMIUM TO VIEW 2 MORE

TOTAL PAGES IN THIS WEBSITE

7

OTHER SITES

prevenar.com

IIS7

The menu below contains a list of countries in which either PREVENAR. Depending on country, PREVENAR. May have been replaced by PREVENAR 13. Please check with your local health authorities. Manufactured by Wyeth Pharmaceuticals Inc. Marketed by Pfizer Inc. 265798-02 2010 Pfizer Inc. April 2010. This site is intended for use by health care professionals only in those countries where the product has received marketing authorizations. Please read our Privacy Policy. And Terms and Conditions.

prevenar.cz

Veřejnost - Prevenar 13

Pomáhá chránit děti a dospělé osoby proti závažným pneumokokovým infekcím. Novinky Prevenar 13 pro děti. Novinky Prevenar 13 pro dospělé. Pomáhá chránit děti a dospělé osoby proti závažným pneumokokovým infekcím. Očkování vakcínou Prevenar 13. Proti pneumokokovým onemocněním pomáhá chránit před 13 typy pneumokoka, včetně nebezpečných typů 19A a 3. 1 dávka vakcíny přispívá k dlouhodobé ochraně bez nutnosti přeočkování! Je sportování po očkování rizikem? Nepodceňujte zápal plic. Může skončit i smrtí. Platn...

prevenar13.co.kr

프리베나13(Prevenar13)

1 생후 6주 이상부터 만 17세 까지의 영아, 어린이 및 청소년. 생후 6주 이상부터 만 17세 까지의 영아, 어린이 및 청소년에서 폐렴구균(혈청형 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, 23F)으로 인하여 생기는 침습성 질환의 예방. 생후 6주 이상부터 만 17세 까지의 영아, 어린이 및 청소년에서 폐렴구균(혈청형 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, 23F)으로 인하여 생기는 급성 중이염의 예방. 단, 혈청형 1, 3, 5, 6A, 7F, 19A에 의한 급성 중이염에 대한 유효성 자료는 이용가능하지 않다). 생후 6주 이상부터 만17세 까지의 영아, 어린이 및 청소년에서 폐렴구균(혈청형 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, 23F)으로 인하여 생기는 폐렴의 예방. 2 18세 이상의 성인. 이는 이 약으로 인해 유도된 면역반응에 기초한 것이다.

prevenar13.co.nz

Prevenar13

Skip directly to content. The Symptoms of Meningitis. The Symptoms of Meningitis. Give your child the broadest coverage against pneumococcal disease. PREVENAR 13 is a vaccine that helps immunise your baby against pneumococcal disease. It is fully funded as part of the National Immunisation Schedule. To find out more about Prevenar 13, speak to your doctor or nurse about the benefits and possible risks. WHO Weekly Epidemiological Record NO. 14, 6 April 2012. Ph 0800 736 363.V11014. Immunisation sc...Regis...

prevenar13.com

IIS7

The menu below contains a list of countries in which either PREVENAR. Depending on country, PREVENAR. May have been replaced by PREVENAR 13. Please check with your local health authorities. Manufactured by Wyeth Pharmaceuticals Inc. Marketed by Pfizer Inc. 265798-01 2010 Pfizer Inc. April 2010. This site is intended for use by health care professionals only in those countries where the product has received marketing authorizations. Please read our Privacy Policy. And Terms and Conditions.

prevenar13.eu

Prevenar13.eu > Home

Summary of Prevenar 13* product characteristics. Welcome to Prevenar13.eu. The European Commission has granted Pfizer Inc a European marketing authorization for its pneumococcal conjugate vaccine, Prevenar 13* (Pneumococcal Polysaccharide Conjugate Vaccine [13-valent, adsorbed]). Prevenar 13 is indicated for active immunization for the prevention of invasive disease, pneumonia, and acute otitis media caused by 13 Streptococcus pneumoniae serotypes in infants and children from 6 weeks to 5 years of age.

prevenar13publications.com

Prevenar Publications Tracker

prevenas.com

Welcome prevenas.com - BlueHost.com

Web Hosting - courtesy of www.bluehost.com.

prevenases.es

Félicitations ! Votre domaine a bien été créé chez OVH !

Votre domaine prevenases.es. A bien été créé chez OVH. Accédez à votre Webmail OVH. Depuis votre Espace Client Web. Consultez la liste des. Vous pouvez dès à présent lui associer un hébergement,. En choisissant la solution la plus adaptée à vos besoins :. Pour héberger vos projets Web :. Site Internet, boutique en ligne,. Alliez la flexibilité du Cloud. À la liberté du dédié. Avec nos solutions VPS clef en main. Accompagnez vos projets Web. Vers une nouvelle étape. Hébergez vos sites Web.

prevenaula.com

www.prevenaula.com

Al mejor precio, crear tu web. De calidad. Además, servidor cloud.

prevenauto.com

Prevenauto | Login

Derechos Reservados 2014 - Inversiones Impormotor LLS C.A. J-40336608-0. Versión 2.0. IMPORMOTOR, L.L.S. Es una empresa dedicada a la importación y comercialización de repuestos, grasas y lubricantes de marcas como Chevrolet, Ford, Fiat, Hyundai, Kia, Mitsubishi, Toyota, entre otras. Historial de Vehículos en Mano de Obra y Gastos. Órdenes de Servicio, Mantenimiento y Reparación. Inventarios y Almacenes Personalizados. Proyecció de Necesidades de Suministros y Partes. Talleres y Mecánicos.